ID: h-7478dba3ed
Hypothesis
Loss of pericyte-derived pleiotrophin is a key disease-modifying consequence of pericyte senescence
The major pathological effect of pericyte senescence may be failure of a protective trophic secretome, especially pleiotrophin, rather than SASP alone.
EvidencePending (0%)📖 0 cit🗣 1 debates✓ 5 support✗ 2 oppose
✓ All Quality Gates Passed
🧪 Overview
The major pathological effect of pericyte senescence may be failure of a protective trophic secretome, especially pleiotrophin, rather than SASP alone. In this view, trophic replacement could rescue neurons and microcirculation even if senescent pericytes persist, but the hypothesis is currently better suited as a rescue-arm mechanism than as a standalone drug thesis.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["PTN Pleiotrophin<br/>Heparin-binding Growth Factor"]
B["PTPRZ1 Receptor Binding<br/>Tyrosine Phosphatase Zeta"]
C["ALK and SDC3 Co-receptors<br/>Growth and Survival Signals"]
D["Neuronal Development<br/>Axon Guidance and Plasticity"]
E["Angiogenesis Promotion<br/>Endothelial Cell Migration"]
F["PTN Overexpression<br/>Tumorigenesis and Repair Dysregulation"]
G["PTN Neutralization<br/>Anti-PTN Antibody or siRNA"]
A --> B
B --> C
C --> D
C --> E
F -.->|"excessive"| C
G -.->|"modulates"| A
style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
style G fill:#1b5e20,stroke:#81c784,color:#81c784⚖️ Evidence
⚖️ Evidence Matrix5 supports2 contradicts
Supports
Acute pericyte loss causes circulatory failure, pleiotrophin depletion, and neuron loss, implicating PTN as a protective pericyte-derived factor.
Supports
Pericyte loss: a key factor inducing brain Aβ40 accumulation and neuronal degeneration in cerebral amyloid angiopathy.
Supports
Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives.
Supports
Chronic Cocaine Use Causes Changes in the Striatal Proteome Depending on the Endogenous Expression of Pleiotrophin.
Supports
[Midkine in relation to development and pathological status of the nervous system].
Contradicts
The evidence comes from acute pericyte ablation and does not show that chronic senescent pericytes in AD are harmful mainly through PTN suppression.
Contradicts
PTN restoration may spare neurons while leaving BBB leak, perfusion failure, and inflammatory pathology unresolved.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — PTN
No curated PDB or AlphaFold mapping for PTN yet. Search RCSB →
🧠 GTEx v10 Brain ExpressionJSON
Median TPM across 13 brain regions for PTN from GTEx v10.
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for PTN.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
💰 Estimated Development
Cost
$0
Timeline
—
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.3%
Volatility
Low
0.0096
Events (7d)
2
Price History
▲2.6%💾 Resource Usage
LLM Tokens
17,540
$0.0526
Total Cost
$0.0526
🔮 Predictions
🔎 Predictions vs Observations2 predictions · 0 with recorded observations
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF pericyte senescence causes neurodegeneration primarily through PTN loss (rather than SASP), THEN exogenous PTN administration to pericyte-senescent models will significantly reduce neuronal death a | ≥30% reduction in neuronal apoptosis and ≥25% improvement in cerebral blood flow/BBB integrity | — no observation — | pending | 0.65 |
| IF PTN loss is the key disease-modifying consequence of pericyte senescence, THEN selective knockdown of PTN in pericytes (without inducing senescence markers) will reproduce neurodegeneration phenoty | Significant neuronal loss (≥25% reduction in neuron count) and impaired cerebral perfusion within 6 weeks of PTN knockdown | — no observation — | pending | 0.60 |
🔮 Falsifiable Predictions (2)
pendingconf 65%
IF pericyte senescence causes neurodegeneration primarily through PTN loss (rather than SASP), THEN exogenous PTN administration to pericyte-senescent models will significantly reduce neuronal death and improve microcirculation within 4–8 weeks, even while senescent pericytes persist
Predicted outcome: ≥30% reduction in neuronal apoptosis and ≥25% improvement in cerebral blood flow/BBB integrity
Falsification: No significant improvement in neuronal survival or microcirculation despite PTN supplementation, OR improvements are contingent on clearance of senescent pericytes
pendingconf 60%
IF PTN loss is the key disease-modifying consequence of pericyte senescence, THEN selective knockdown of PTN in pericytes (without inducing senescence markers) will reproduce neurodegeneration phenotypes and microvascular dysfunction
Predicted outcome: Significant neuronal loss (≥25% reduction in neuron count) and impaired cerebral perfusion within 6 weeks of PTN knockdown
Falsification: PTN knockdown alone does not cause neuronal loss or vascular dysfunction; neurodegeneration requires concurrent induction of broader senescence markers
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesizer
| source | v1_phase_c_backfill |
| origin_type | debate_synthesizer |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.